RenovoRx, Inc. (RNXT)

CIK 0001574094 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
FY-2025
Latest Q1-2026 8-K (2026-05-14) · 99.1
Latest FY-2025 8-K (2026-03-30) · 99.1
Q3-2025 8-K (2025-11-13) · 99.1
Q2-2025 8-K (2025-08-14) · 99.1
Q1-2025 8-K (2025-05-15) · 99.1
FY-2024 8-K (2025-04-01) · 99.1  |  8-K (2024-11-14) · 99.1
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 8-K (2023-11-14) · 99.1
Q3-2023 8-K (2023-08-17) · 99.1
Q2-2023 8-K (2023-05-15) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Statements
Balance Sheets
Balance Sheets (P)
Condensed Statements of Stockholders Equity (unaudited)
—
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (unaudited)
—
Statements of Operations
Statements of Operations and Comprehensive Loss
Statements of Cash Flows
Statements of Convertible Preferred Stock and Stockholders' Equity (deficit)
Notes
Accrued Expenses
Business and Principal Activities
Commitments and Contingencies
Common Stock Warrants
Cybersecurity Risk Management and Strategy Disclosure
—
Cybersecurity Risk Management, Strategy, and Governance
—
Employee Benefit Plans
—
Equity Incentive Plan
—
Equity Incentive Plan Stock-based Compensation Expense
Equity Incentive Plan Stock-based Compensation Expense and Common Stock Warrants
—
Equity Incentive Plan Stock-based Compensation Expense and Warrants
—
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Inventory
Leases, Commitments and Contingencies
Net Loss Per Share
Pay Vs Performance Disclosure
Property and Equipment, Net
Related Party Transactions
Segment Information
Short-term Marketable Securities
Significant Accounting Policies
—
Subsequent Events
Summary of Significant Accounting Policies
Warrants
—